Víctor Guallar Tasies

Víctor Guallar Tasies

Barcelona Supercomputing Center - Centro Nacional de Supercomputación

Life & Medical Sciences

Professor Guallar performed his undergraduate at the Autonomous University of Barcelona (Spain), with a major in Chemistry, followed by a joined PhD in physical chemistry at UC Berkeley and Autonomous University of Barcelona. Afterwards, he moved for a postdoctoral research position (2000-2003) to Columbia University in New York City. In 2003 he got a teanured position as an assistant Professor at the Biochemistry and Molecular Biophysics department at the School of Medicine in Washington University in St. Louis. In 2006 he was appointed ICREA Research Professor in the Life Science Department at the Barcelona Supercomputing Center (BSC), were he has been developing his research group. In 2016 he co-founded Nostrum Biodiscovery, the first spin-off from the BSC.
He is the recipient of numerous prestigious grants, such as an advanced ERC, having trained 20 PhD students and published more than 200 papers.

Research interests

In the EAPM lab at BSC we are devoted to the development and application of computational algorithms in molecular modeling. Using techniques such as Monte Carlo simulations, bioinformatics, machine learning and mixed quantum mechanics/molecular mechanics methods, we face different biophysical and biochemical challenges, including characterization, bioprospecting and engineering of enzymes for industrial and biomedical applications, software development for more efficient early stages of drug discovery and immunology. Along 2024, particular interest has focused on: i) engineering an E. Coli bacterium for a la carte biochemistry (for plastic degradation and cascade reactions), ii) implementing active learning AI approaches for efficient virtual drug screening, iii) vaccine development through combining AI and molecular modelling

Selected publications

- Santema LL, Rotilio L, Xiang RT, Tjallinks G, Guallar V, Mattevi A & Fraaije MW 2024, 'Discovery and biochemical characterization of thermostable glycerol oxidases', Applied microbiology and biotechnology, 108 - 1 - 21 - 21.
- Robles-Martín A, Roda S, Muñoz-Tafalla R & Guallar V 2024, 'Behind the Scenes of PluriZyme Designs', Eng, 5 - 1 - 91 - 103.
- Vidal P, Robles-Martín A, Fernandez-Lopez L, Gonzalez-Alfonso JL, Almendral D, Muñoz-Tafalla R, Plou FJ, Guallar V & Ferrer M 2024, 'Unlocking a Key Residue in a Lipase for Efficient Polyethylene Terephthalate (PET) Hydrolysis and Influencing Depolymerization Product Profiles', Chemcatchem, 16 - 23.
- Ciudad A, Morales A, Malo L, Filella I, Guallar V, Molina A 2024, 'Scoreformer: A Surrogate Model For Large-Scale Prediction of Docking Scores'. Paper in conference. ICML 2024 Workshop ML4LMS, Viena.
- Ávila-Nieto C, Vergara-Alert J, Amengual-Rigo P. et al. 2024, 'Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection', Nat Commun 15, 2349.